InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,572.85
(
0.10%
)
US TECH 100
19,963.60
(
0.59%
)
Dow Jones
39,344.79
(
-0.08%
)
Brent Oil
85.41
(
-0.01%
)
Bitcoin
57,501.42
(
1.40%
)
Post# of 252525
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

rfj1862

Send PM Follow Ignore
Followers 39
Posts 1714
Boards Moderated 0
Alias Born 10/05/2005

rfj1862

Re: Preciouslife1 post# 39846

Saturday, 12/23/2006 7:23:16 PM

Saturday, December 23, 2006 7:23:16 PM

Post# of 252525
>Following a year of furious M&A activity, France's Sanofi-Aventis has revealed that it is interested in buying a biotechnology firm with "three or four products" that is in the mould of US-based stellar performer Genentech.<

Anyone want to guess?

You forgot to add:

>BMI concurs with the French firm's rationale but is highly sceptical that it will secure a company of Genentech's pedigree.<
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up